Policyholder Services

Does OMIC cover physicians who perform Transpupillary Thermo Therapy (TTT)?

Yes! Although this treatment for macular degeneration is not yet FDA-approved and is still undergoing studies, OMIC will extend coverage for transpupillary thermo therapy as an off-label use of an FDA-approved diode laser. Physicians performing this procedure should obtain appropriate informed consent.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.